Clinical Evaluation of Xpert Xpress CoV-2/Flu/RSV plus and Alinity m Resp-4-Plex Assay
- PMID: 38611596
- PMCID: PMC11012021
- DOI: 10.3390/diagnostics14070683
Clinical Evaluation of Xpert Xpress CoV-2/Flu/RSV plus and Alinity m Resp-4-Plex Assay
Abstract
The performance of the Xpert Xpress CoV-2/Flu/RSV plus and Alinity m Resp-4-Plex Assays were evaluated using 167 specimens, including 158 human respiratory specimens and 9 external quality assessment program (EQAP) samples. For respiratory specimens, CoV-2/Flu/RSV plus exhibited perfect agreement with the standard-of-care (SOC) methods (Cohen's κ: 1, 100% agreement). The overall positive and negative percent agreement (PPA and NPA) were 100%, with 95% confidence intervals of 96.50 to 100% and 85.70 to 100%, respectively. On the other hand, Resp-4-Plex revealed an almost perfect agreement with the SOC methods (Cohen's κ: 0.92, 97.71% agreement). The overall PPA and NPA were 100% (95.76 to 100%) and 88.46% (70.20 to 96.82%), respectively. For EQAP samples, the results of CoV-2/Flu/RSV plus (9/9) and Resp-4-Plex (4/4) were concordant with the expected results. The experimental limit of detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was the lowest (25 copies/mL for both methods), and that of the respiratory syncytial virus was the highest (400 copies/mL for CoV-2/Flu/RSV plus and 100 copies/mL for Resp-4-Plex). Threshold cycle (Ct) value correlation showed a large positive linear association between CoV-2/Flu/RSV plus and Resp-4-Plex, with R-squared values of 0.92-0.97, and on average, the Ct values of CoV-2/Flu/RSV plus were higher than that of Resp-4-Plex by 1.86-2.78, except for Flu A1 target (-0.66). To conclude, the performance of both assay was comparable to the SOC methods for both upper and lower respiratory specimens. Implementation of these rapid assay may reinforce the diagnostic capacity for the post-pandemic co-circulation of SARS-CoV-2 and other respiratory viruses.
Keywords: Alinity m Resp-4-Plex; RSV; SARS-CoV-2; Xpert Xpress CoV-2/Flu/RSV plus; influenza.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Evaluation of the Alinity m Resp-4-Plex Assay for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2, Influenza A Virus, Influenza B Virus, and Respiratory Syncytial Virus.Microbiol Spectr. 2022 Feb 23;10(1):e0109021. doi: 10.1128/spectrum.01090-21. Epub 2022 Feb 2. Microbiol Spectr. 2022. PMID: 35107357 Free PMC article.
-
Rapid Evaluation of the Xpert® Xpress CoV-2 plus and Xpert® Xpress CoV-2/Flu/RSV plus Tests.Diagnostics (Basel). 2022 Dec 22;13(1):34. doi: 10.3390/diagnostics13010034. Diagnostics (Basel). 2022. PMID: 36611325 Free PMC article.
-
Evaluation of the Xpert Xpress SARS-CoV-2/Flu/RSV Assay for Simultaneous Detection of SARS-CoV-2, Influenza A and B Viruses, and Respiratory Syncytial Virus in Nasopharyngeal Specimens.J Clin Microbiol. 2021 Mar 19;59(4):e02965-20. doi: 10.1128/JCM.02965-20. Print 2021 Mar 19. J Clin Microbiol. 2021. PMID: 33436456 Free PMC article.
-
Multiplex CLIA-waived point-of-care tests for SARS-CoV-2, influenza A and B, ± other respiratory pathogens: A systematic review.J Am Pharm Assoc (2003). 2024 Jul-Aug;64(4):102090. doi: 10.1016/j.japh.2024.102090. Epub 2024 Apr 9. J Am Pharm Assoc (2003). 2024. PMID: 38604476
-
Diagnostic accuracy of the Cepheid Xpert Xpress and the Abbott ID NOW assay for rapid detection of SARS-CoV-2: A systematic review and meta-analysis.J Med Virol. 2021 Jul;93(7):4523-4531. doi: 10.1002/jmv.26994. Epub 2021 May 3. J Med Virol. 2021. PMID: 33913533 Free PMC article.
Cited by
-
Molecular Detection of Various Non-Seasonal, Zoonotic Influenza Viruses Using BioFire FilmArray and GenXpert Diagnostic Platforms.Viruses. 2025 Jul 10;17(7):970. doi: 10.3390/v17070970. Viruses. 2025. PMID: 40733587 Free PMC article.
References
-
- World Health Organization WHO Coronavirus (COVID-19) Dashboard. [(accessed on 10 February 2024)]. Available online: https://covid19.who.int/table.
-
- GOV.UK Guidance—COVID-19 Response: Living with COVID-19. [(accessed on 2 March 2023)]; Available online: https://www.gov.uk/government/publications/covid-19-response-living-with....
-
- Bloomberg Singapore Confronts the Division and Fear That Come from Living with COVID. [(accessed on 2 March 2023)]. Available online: https://www.bloomberg.com/news/articles/2021-10-14/singapore-confronts-d....
-
- SaxInstitute Public Health Research & Practice Learning to Live with COVID-19 in Australia: Time for a New Approach. [(accessed on 2 March 2023)]. Available online: https://www.phrp.com.au/issues/september-2021-volume-31-issue-3/learning... - PubMed
-
- The Government of the Hong Kong Special Administrative Region Latest Highlights. [(accessed on 2 March 2023)]; Available online: https://www.coronavirus.gov.hk/eng/index.html.
LinkOut - more resources
Full Text Sources
Miscellaneous